|
1
|
Kalra EK: Nutraceutical-definition and
introduction. AAPS PharmSci. 5:E252003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Manach C, Scalbert A, Morand C, Rémésy C
and Jiménez L: Polyphenols: Food sources and bioavailability. Am J
Clin Nutr. 79:727–747. 2004.PubMed/NCBI
|
|
3
|
Birt DF, Walker B, Tibbels MG and Bresnick
E: Anti-mutagenesis and anti-promotion by apigenin, robinetin and
indole-3-carbinol. Carcinogenesis. 7:959–963. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Shukla S and Gupta S: Apigenin: A
promising molecule for cancer prevention. Pharm Res. 27:962–978.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Khan SA, Toledano MB and Taylor-Robinson
SD: Epidemiology, risk factors, and pathogenesis of
cholangiocarcinoma. HPB (Oxford). 10:77–82. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sonakul D, Koompirochana C, Chinda K and
Stitnimakarn T: Hepatic carcinoma with opisthorchiasis. Southeast
Asian J Trop Med Public Health. 9:215–219. 1978.PubMed/NCBI
|
|
7
|
Kobayashi M, Ikeda K, Saitoh S, Suzuki F,
Tsubota A, Suzuki Y, Arase Y, Murashima N, Chayama K and Kumada H:
Incidence of primary cholangiocellular carcinoma of the liver in
japanese patients with hepatitis C virus-related cirrhosis. Cancer.
88:2471–2477. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yamamoto S, Kubo S, Hai S, Uenishi T,
Yamamoto T, Shuto T, Takemura S, Tanaka H, Yamazaki O, Hirohashi K
and Tanaka T: Hepatitis C virus infection as a likely etiology of
intrahepatic cholangiocarcinoma. Cancer Sci. 95:592–595. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Shaib YH, El-Serag HB, Davila JA, Morgan R
and McGlynn KA: Risk factors of intrahepatic cholangiocarcinoma in
the United States: A case-control study. Gastroenterology.
128:620–626. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sorensen HT, Friis S, Olsen JH, Thulstrup
AM, Mellemkjaer L, Linet M, Trichopoulos D, Vilstrup H and Olsen J:
Risk of liver and other types of cancer in patients with cirrhosis:
A nationwide cohort study in Denmark. Hepatology. 28:921–925. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Srisomsap C, Sawangareetrakul P,
Subhasitanont P, Panichakul T, Keeratichamroen S, Lirdprapamongkol
K, Chokchaichamnankit D, Sirisinha S and Svasti J: Proteomic
analysis of cholangiocarcinoma cell line. Proteomics. 4:1135–1144.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Srisomsap C, Subhasitanont P,
Sawangareetrakul P, Chokchaichamnankit D, Ngiwsara L, Chiablaem K
and Svasti J: Comparison of membrane-associated proteins in human
cholangiocarcinoma and hepatocellular carcinoma cell lines.
Proteomics Clin Appl. 1:89–106. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Elmore S: Apoptosis: A review of
programmed cell death. Toxicol Pathol. 35:495–516. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Martin SJ and Green DR: Protease
activation during apoptosis: Death by a thousand cuts? Cell.
82:349–352. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Thornberry NA and Lazebnik Y: Caspases:
Enemies within. Science. 281:1312–1316. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jaattela M: Escaping cell death: Survival
proteins in cancer. Exp Cell Res. 248:30–43. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Levy-Strumpf N and Kimchi A: Death
associated proteins (DAPs): From gene identification to the
analysis of their apoptotic and tumor suppressive functions.
Oncogene. 17:3331–3340. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Brockstedt E, Rickers A, Kostka S,
Laubersheimer A, Dörken B, Wittmann-Liebold B, Bommert K and Otto
A: Identification of apoptosis-associated proteins in a human
Burkitt lymphoma cell line. Cleavage of heterogeneous nuclear
ribonucleoprotein A1 by caspase 3. J Biol Chem. 273:28057–28064.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Prasad SC, Soldatenkov VA, Kuettel MR,
Thraves PJ, Zou X and Dritschilo A: Protein changes associated with
ionizing radiation-induced apoptosis in human prostate epithelial
tumor cells. Electrophoresis. 20:1065–1074. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gupta S, Afaq F and Mukhtar H: Selective
growth-inhibitory, cell-cycle deregulatory and apoptotic response
of apigenin in normal versus human prostate carcinoma cells.
Biochem Biophys Res Commun. 287:914–920. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Choi EJ and Kim GH: Apigenin induces
apoptosis through a mitochondria/caspase-pathway in human breast
cancer MDA-MB-453 cells. J Clin Biochem Nutr. 44:260–265. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xu Y, Xin Y, Diao Y, Lu C, Fu J, Luo L and
Yin Z: Synergistic effects of apigenin and paclitaxel on apoptosis
of cancer cells. PLoS One. 6:e291692011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Khan A, Gillis K, Clor J and Tyagarajan K:
Simplified evaluation of apoptosis using the Muse cell analyzer.
Postepy Biochem. 58:492–496. 2012.PubMed/NCBI
|
|
24
|
Svasti J, Srisomsap C, Subhasitanont P,
Keeratichamroen S, Chokchaichamnankit D, Ngiwsara L, Chimnoi N,
Pisutjaroenpong S, Techasakul S and Chen ST: Proteomic profiling of
cholangiocarcinoma cell line treated with pomiferin from Derris
malaccensis. Proteomics. 5:4504–4509. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ruela-de-Sousa RR, Fuhler GM, Blom N,
Ferreira CV, Aoyama H and Peppelenbosch MP: Cytotoxicity of
apigenin on leukemia cell lines: Implications for prevention and
therapy. Cell Death Dis. 1:e192010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Vargo MA, Voss OH, Poustka F, Cardounel
AJ, Grotewold E and Doseff AI: Apigenin-induced-apoptosis is
mediated by the activation of PKCdelta and caspases in leukemia
cells. Biochem Pharmacol. 72:681–692. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Creagh EM, Conroy H and Martin SJ:
Caspase-activation pathways in apoptosis and immunity. Immunol Rev.
193:10–21. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Caulin C, Salvesen GS and Oshima RG:
Caspase cleavage of keratin 18 and reorganization of intermediate
filaments during epithelial cell apoptosis. J Cell Biol.
138:1379–1394. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Leers MP, Kolgen W, Björklund V, Bergman
T, Tribbick G, Persson B, Björklund P, Ramaekers FC, Björklund B,
Nap M, et al: Immunocytochemical detection and mapping of a
cytokeratin 18 neo-epitope exposed during early apoptosis. J
Pathol. 187:567–572. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Schutte B, Henfling M, Kölgen W, Bouman M,
Meex S, Leers MP, Nap M, Björklund V, Björklund P, Björklund B, et
al: Keratin 8/18 breakdown and reorganization during apoptosis. Exp
Cell Res. 297:11–26. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Mitamura S, Ikawa H, Mizuno N, Kaziro Y
and Itoh H: Cytosolic nuclease activated by caspase-3 and inhibited
by DFF-45. Biochem Biophys Res Commun. 243:480–484. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Joo JH, Yoon SY, Kim JH, Paik SG, Min SR,
Lim JS, Choe IS, Choi I and Kim JW: S100A6 (calcyclin) enhances the
sensitivity to apoptosis via the upregulation of caspase-3 activity
in Hep3B cells. J Cell Biochem. 103:1183–1197. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Makino E, Sakaguchi M, Iwatsuki K and Huh
NH: Introduction of an N-terminal peptide of S100C/A11 into human
cells induces apoptotic cell death. J Mol Med (Berl). 82:612–620.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hamada S, Satoh K, Hirota M, Kanno A,
Ishida K, Umino J, Ito H, Kikuta K, Kume K, Masamune A, et al:
Calcium-binding protein S100P is a novel diagnostic marker of
cholangiocarcinoma. Cancer Sci. 102:150–156. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Nakanuma Y and Sato Y: Hilar
cholangiocarcinoma is pathologically similar to pancreatic duct
adenocarcinoma: Suggestions of similar background and development.
J Hepatobiliary Pancreat Sci. 21:441–447. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wu Z, Boonmars T, Nagano I, Boonjaraspinyo
S, Srinontong P, Ratasuwan P, Narong K, Nielsen PS and Maekawa Y:
Significance of S100P as a biomarker in diagnosis, prognosis and
therapy of opisthorchiasis-associated cholangiocarcinoma. Int J
Cancer. 138:396–408. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Noolu B, Ajumeera R, Chauhan A, Nagalla B,
Manchala R and Ismail A: Murraya koenigii leaf extract inhibits
proteasome activity and induces cell death in breast cancer cells.
BMC Complement Altern Med. 13:72013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Beyer AL, Christensen ME, Walker BW and
LeStourgeon WM: Identification and characterization of the
packaging proteins of core 40S hnRNP particles. Cell. 11:127–138.
1977. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Cooper TA, Wan L and Dreyfuss G: RNA and
disease. Cell. 136:777–793. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Arango D, Morohashi K, Yilmaz A, Kuramochi
K, Parihar A, Brahimaj B, Grotewold E and Doseff AI: Molecular
basis for the action of a dietary flavonoid revealed by the
comprehensive identification of apigenin human targets. Proc Natl
Acad Sci USA. 110:E2153–E2162. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Lindquist S and Craig EA: The heat-shock
proteins. Annu Rev Genet. 22:631–677. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Calderwood SK and Ciocca DR: Heat shock
proteins: Stress proteins with Janus-like properties in cancer. Int
J Hyperthermia. 24:31–39. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Takayama S, Reed JC and Homma S:
Heat-shock proteins as regulators of apoptosis. Oncogene.
22:9041–9047. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Kubota H, Yamamoto S, Itoh E, Abe Y,
Nakamura A, Izumi Y, Okada H, Iida M, Nanjo H, Itoh H and Yamamoto
Y: Increased expression of co-chaperone HOP with HSP90 and HSC70
and complex formation in human colonic carcinoma. Cell Stress
Chaperones. 15:1003–1011. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Sun W, Xing B, Sun Y, Du X, Lu M, Hao C,
Lu Z, Mi W, Wu S, Wei H, et al: Proteome analysis of hepatocellular
carcinoma by two-dimensional difference gel electrophoresis: Novel
protein markers in hepatocellular carcinoma tissues. Mol Cell
Proteomics. 6:1798–1808. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Erlich RB, Kahn SA, Lima FR, Muras AG,
Martins RA, Linden R, Chiarini LB, Martins VR and Moura Neto V:
STI1 promotes glioma proliferation through MAPK and PI3K pathways.
Glia. 55:1690–1698. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Wang TH, Chao A, Tsai CL, Chang CL, Chen
SH, Lee YS, Chen JK, Lin YJ, Chang PY, Wang CJ, et al:
Stress-induced phosphoprotein 1 as a secreted biomarker for human
ovarian cancer promotes cancer cell proliferation. Mol Cell
Proteomics. 9:1873–1884. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Tanioka T, Nakatani Y, Semmyo N, Murakami
M and Kudo I: Molecular identification of cytosolic prostaglandin
E2 synthase that is functionally coupled with cyclooxygenase-1 in
immediate prostaglandin E2 biosynthesis. J Biol Chem.
275:32775–32782. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Simpson NE, Lambert WM, Watkins R,
Giashuddin S, Huang SJ, Oxelmark E, Arju R, Hochman T, Goldberg JD,
Schneider RJ, et al: High levels of Hsp90 cochaperone p23 promote
tumor progression and poor prognosis in breast cancer by increasing
lymph node metastases and drug resistance. Cancer Res.
70:8446–8456. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Gausdal G, Gjertsen BT, Fladmark KE, Demol
H, Vandekerckhove J and Doskeland SO: Caspase-dependent,
geldanamycin-enhanced cleavage of co-chaperone p23 in leukemic
apoptosis. Leukemia. 18:1989–1996. 2004. View Article : Google Scholar : PubMed/NCBI
|
